510(k) Report

510(k) · Cleared

Cleared

SST Saliva Supporting Tablets

K023046510(k) TraditionalCleared Dec 2, 200281-day reviewClass I21 CFR 864.1850

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Sinclair Pharmaceuticals, Ltd. · LED Stains, Chemical Solution

Cleared on Dec 2, 2002 as substantially equivalent to K981693 (Gebauer Co., 2001) and 1 other predicate after an 81-day review. Its family tree reaches back 2 generations to 1988. 1 later device descends from it.

Decided
Dec 2, 2002
Review
81 days
Class
Class I
Product code
LED
Recalls
None
Predicates
2

Its longest line of descent runs back 2 generations to K874106 (1988). 3 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2001: 1 other ancestor2004: 1 descendant clearedK874106 · Glandosane (Salivart) Synthetic Saliva · Fresenius USA, Inc. · 1988K991938 · Caphosol Artificial Saliva · Inpharma A.S. · 19991990200020102020
Other ancestors, by generationDescendants, by generation 1 generation back: 1 other ancestor 1 generation forward: 1 descendant K991938 · Caphosol Artificial Saliva · Inpharma A.S. · 1999K874106 · Glandosane (Salivart) Synthetic Saliva · Fresenius USA, Inc. · 19880
  1. Root · 2 generations backK874106 Glandosane (Salivart) Synthetic SalivaFresenius USA, Inc. · 1988
  2. 1 generation backK991938 Caphosol Artificial SalivaInpharma A.S. · 1999
  3. This deviceK023046 SST Saliva Supporting TabletsSinclair Pharmaceuticals, Ltd. · 2002
  4. Descendant · cites it directly · 0 of its ownK041563 Oasis Dry Mouth Relief Discs or Oasis Mouth Moisturizing DiscsGlaxosmithkline Consumer Healthcare, L.P. · 2004

Most influential descendants

Showing 1 of 1 · See all
  • K041563Oasis Dry Mouth Relief Discs or Oasis Mouth Moisturizing DiscsGlaxosmithkline Consumer Healthcare, L.P. · 2004 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−2K874106Glandosane (Salivart) Synthetic SalivaFresenius USA, Inc.1988—
−1K991938Caphosol Artificial SalivaInpharma A.S.1999—
0 (this device)K023046SST Saliva Supporting TabletsSinclair Pharmaceuticals, Ltd.2002—
+1K041563Oasis Dry Mouth Relief Discs or Oasis Mouth Moisturizing DiscsGlaxosmithkline Consumer Healthcare, L.P.2004—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
200110

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200410
FIG. 1 — Lineage of K023046, 1988–2004Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LED? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K981693Salivart Oral Moisturizer Model Number 03866-009-75 Salivart Oral Moisturizer Model…
Summary page 1
…ssification Names: Dental: Saliva, artificial 3. Devices to Which New Device is Substantially Equivalent: Gebauer Company: Salivart cleared in 5 1O(k) K98 1693 and Inpharma AB: Caphosol cleared in 5 1O(k) K99 1938 4. Device Description: SST1” is formulated as a tablet that is allowed t…
Gebauer Co.20012
*K991938Caphosol Artificial Saliva
Summary page 1
…ificial 3. Devices to Which New Device is Substantially Equivalent: Gebauer Company: Salivart cleared in 5 1O(k) K98 1693 and Inpharma AB: Caphosol cleared in 5 1O(k) K99 1938 4. Device Description: SST1” is formulated as a tablet that is allowed to dissolve slowly in the mouth. The tablets are presen…
Inpharma A.S.1999—

Also cleared against K981693: 7 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K041563Oasis Dry Mouth Relief Discs or Oasis Mouth Moisturizing DiscsGlaxosmithkline Consumer Healthcare, L.P.20040

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 11.3 years on median.
  • 1 of the 3 ancestors has a recall of any class.
  • Of its descendants, K041563 (Glaxosmithkline Consumer Healthcare, L.P., 2004) has gone furthest, with 0 descendants of its own.
  • 7 other devices also cite its predicate K981693.

How does its category compare?

All LED devices

LED Stains, Chemical Solution: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · LED

FDA has decided no LED device since 2007.

Median 510(k) review, days · LED

Too few LED 510(k)s in any year since 2007 to give a median.

Recalls per year · LED

No recall names LED since 2007.

Adverse event reports per year · LED

5in 2025

2022: 12025: 5
2007high 5 (2025) · low 0 (2007)2025

MAUDE reports naming product code LED, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—00
20090—00
20100—00
20110—00
20120—00
20130—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—01
20230—00
20240—00
20250—05
20260—0—

What is it indicated for?

Under the supervision of a healthcare professional, SINCLAIR SSTTM promotes lubrication of oral mucosa that may be dry (xerostomia) due to, as may occur in a variety of circumstances including, medication, chemo or radiotherapy, Sjogren's Syndrome or oral inflammation. SINCLAIR SSTTM provides temporary relief for damaged salivary function.

Over the counter labeling stipulates that SINCLAIR SSTTM is suitable for temporary relief of dry mouth symptoms.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K023046: SST Saliva Supporting Tablets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K023046

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026